Publications for all Oxford Principal Investigators within the CAMS Oxford Institute are included here, please use the search functions for publications related to specific Principal Investigators.
Comparison of the immunogenicity of five COVID-19 vaccines in Sri Lanka.
Jeewandara C. et al, (2022), Immunology, 167, 263 - 274
Kinetics of immune responses to SARS-CoV-2 proteins in individuals with varying severity of infection and following a single dose of the AZD1222
Jayathilaka D. et al, (2022), Clinical and Experimental Immunology, 208, 323 - 331
Kinetics of immune responses to the AZD1222/Covishield vaccine with varying dose intervals in Sri Lankan individuals
Jeewandara C. et al, (2022), Immunity, Inflammation and Disease, 10
Sensitivity and specificity of two WHO approved SARS-CoV2 antigen assays in detecting patients with SARS-CoV2 infection.
Jeewandara C. et al, (2022), BMC infectious diseases, 22
Comparison of different sequencing techniques for identification of SARS-CoV-2 variants of concern with multiplex real-time PCR.
Ranasinghe D. et al, (2022), PloS one, 17
Comparison of the lmmunogenicity of five COVID-19 vaccines in Sri Lanka
Jeewandara JMKC. et al, (2022), JOURNAL OF IMMUNOLOGY, 208
Molecular Epidemiology of AY.28 and AY.104 Delta Sub-lineages in Sri Lanka.
Ranasinghe D. et al, (2022), Frontiers in public health, 10
Immune Responses to a Single Dose of the AZD1222/Covishield Vaccine at 16 Weeks in Individuals in Sri Lanka
Jeewandara C. et al, (2021), The Journal of Immunology, 207, 2681 - 2687
Comparison of two assays to detect IgG antibodies to the receptor binding domain of SARS‑CoV‑2 as a surrogate marker for assessing neutralizing antibodies in COVID-19 patients.
Kamaladasa A. et al, (2021), International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 109, 85 - 89
Immune responses to a single dose of the AZD1222/Covishield vaccine in health care workers
Jeewandara C. et al, (2021), Nature Communications, 12
Differences in the SARS-COV2 IgA and IgG responses to S1, S2, RBD and N regions following a single dose of AZD1222 compared to natural infection
Jayathilaka D. et al, (2021), EUROPEAN JOURNAL OF IMMUNOLOGY, 51, 70 - 70
Ex vivo IFN gamma T cell responses to a single dose of the AZD1222 vaccine 12 weeks following immunization
Pushpakumara PD. et al, (2021), EUROPEAN JOURNAL OF IMMUNOLOGY, 51, 295 - 295
Genomic and Epidemiological Analysis of SARS-CoV-2 Viruses in Sri Lanka.
Jeewandara C. et al, (2021), Frontiers in microbiology, 12
SARS-CoV-2 neutralizing antibodies in patients with varying severity of acute COVID-19 illness.
Jeewandara C. et al, (2021), Scientific reports, 11
Seroprevalence of SARS-CoV-2 Infection in the Colombo Municipality Region, Sri Lanka.
Jeewandara C. et al, (2021), Frontiers in public health, 9
Transmission dynamics, clinical characteristics and sero-surveillance in the COVID-19 outbreak in a population dense area of Colombo, Sri Lanka April- May 2020.
Jeewandara C. et al, (2021), PloS one, 16
Similarities and differences between the 'cytokine storms' in acute dengue and COVID-19.
Dayarathna S. et al, (2020), Scientific reports, 10
Phenotype and functionality of follicular helper T cells in patients with acute dengue infection.
Wijesinghe A. et al, (2020), Journal of biomedical science, 27
Development of an ELISA to assess Japanese encephalitis virus NS1 protein antibody responses in a community cohort in Sri Lanka
Ariyaratne D. et al, (2020), 2020 From Innovation to Impact, FITI 2020
Identifying an immunodominant epitope of dengue non-structural protein 1 (NS1) in acute secondary dengue infections for vaccine development or development of treatment modalities
Ramu ST. et al, (2020), 2020 From Innovation to Impact, FITI 2020